We previously repotted that the K562 cell line K562YO expressed a high level of the c-kit gene. In this study, we analyzed the mechanism of this expression and investigated the effects of the serine/threonine kinases such as protein kinase C (PKC) and cyclic adenosine 3',5'-monophosphate (CAMPI-dependent kinase (PKA) on it. The half-life of the c-kit mRNA in K562YO cells was greater than 10 hours, compared with 2 hours in the original K562 cells, which expressed a very low level of c-kit mRNA. This prolonged half-life can contribute to the high level of c-kit expression in K562YO cells. Cycloheximide (CHX), a protein synthesis inhibitor, caused increases in c-kit mRNA levels in K562YO cells. 12-0-tetradecanoylphorbol-13-acetate (TPA), by which PKC was activated at first and downregulated in a late phase, gradually decreased c-kit rnRNA in K562YO cells until 9 hours and then returned to the control level 24 hours after treatment. TPA also rapidly decreased c-kit protein level on the membranes. In whole cells, c-kit protein was also decreased 6 hours after incubation with TPA. Calphostin C, a light-depen-OME HEMATOLOGICALLY malignant cells express a high level of protooncogenes. For example, HL60 cells express the c-myc gene through gene amplification.'.' Overexpression of protooncogenes causes various biologic phenomena, including malignant transformation. We previously described a K562 subclone (K562YO) that expressed a high level of c-kit mRNA, and c-kit protein on membranes was phosphorylated by stem cell factor (SCF).3 The c-kit protein, a receptor for SCF, belongs to platelet-derived growth factorkolony-stimulating factor 1 (CSF-1) receptor families that have tyrosine kinase a~t i v i t y .~.~ SCFlc-kit signals play an important role in the proliferation and differentiation of hematopoietic progenitor SCF is also believed to be a growth factor or an autocrine growth factor for some cancer cell^.""^ Therefore, the mechanisms that control the expression of c-kit gene are of interest. Other cytokines, such as interleukin-3 (IL-3), granulocyte-macrophage CSF (GM-CSF), erythropoietin, and the protooncogene c-myb, reportedly modulate the expression of the ckit gene.l5.l6 On the other hand, signal transduction systems dependent on serinelthreonine kinases, protein kinases C dent PKC inhibitor, decreased c-kit mRNA levels within 30 minutes in a light-dependent manner. It also decreased ckit protein in whole cells 2 hours after the addition. However, it increased the amount of c-kit protein on the cell surfaces. Dibutyryl cyclic AMP (dbc-AMP) increased c-kit mRNA as well as c-kit protein on membranes and in whole cells. Runon transcriptional assay suggested that the agent (dbc-AMP) enhanced the transcription rate of the gene. These results suggest that c-kit protein on the membranes is downregulated by PKC activation and upregulated by PKC inhibition. In the whole cell lysate, c-kit proteins are decreased by PKC inhibition through downregulation of mRNA. On the other hand, the elevation of an intracellular cAMP level causes upregulation of both the mRNA and c-kit protein on membranes and in whole cells through enhanced transcription. Thus, c-kit gene expression is apparently modulated by PKC and PKA.
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(PKC) and A (PKA), modulate the expression of various genes at some point from transcription to protein turnover. For example, activation of PKC by 12-0-tetradecanoylphorbol-13-acetate (TPA) induces downregulation of epidermal growth factor (EGF), insulin, and CSF-l receptors through accelerated protein turnover.'"l9 Moreover, TPA inhibited the synthesis of the CSF-1 receptor in mature monocytes by destabilizing its mRNA.*' Cyclic adenosine 3',5'-monophosphate (CAMP) activates gene transcription through activation of the catalytic subunit of CAMP-dependent protein kinase.2' It stimulates somatostatin gene transcription through cyclic AMP response element binding protein (CREB) phosphorylation.22 To investigate the mechanism of c-kit expression in KS62YO cells, we compared the stability of c-kit mRNA in original K562 cells and K562YO cells and studied the effects of PKA and PKC modulators on expression of the c-kit gene in KS62YO cells.
MATERIALS AND METHODS
Reagents and cells. TPA and dibutyryl cAMP (dbc-AMP) were purchased from Sigma Chemical CO (St. Louis, MO). Calphostin C'3.24 was a gift from KYOWA HAKKO CO (Tokyo, Japan). K562YO cells that highly expressed the c-kit gene and original K562 cells that had low but detectable c-kit mRNA levels were used in this study. These cells were seeded in RPM1 1640 medium (Nissui, Tokyo, Japan) supplemented with 10% fetal calf serum and incubated with appropriate agents for time periods indicated in the figure legends at 37°C in a humidified atmosphere containing 5% C@. Cell viability was always greater than 95% in all experiments, as assessed by 0.025% trypan blue dye exclusion.
RNA preparation and Northern blot. Total RNA was prepared using ISOGEN (Nippongene, Tokyo, Japan), which involves a modification of the guanidine thiocyanate-phenokhloroform procedure. Total RNA (1 5 pg) was denatured with formaldehyde and fractionated by electrophoresis on 1 % formaldehyde agarose. The RNA was transferred to a nylon membrane (BIODYNE, Pall Corp, East Hills, NY) with 20x sodium chloride-sodium citrate (SSC). The c-kit probe ob- tained from the American Type Culture Collection (ATCC; Bethesda, MD) contained the 1.3-kb Sst I fragment encoding part of the extracellular domain of c-kif. After prehybridization. the membranes were hybridized with the randomly labeled "P probe at 43°C for 20 hours. The membranes were washed in 2X SSC. 0.1% sodium dodecyl sulfate (SDS) for 30 minutes at room temperature, then twice in 0.1 X SSC, 0.1% SDS for 30 minutes at 55°C. The blots were exposed to x-ray film at -80°C for 48 hours unless otherwise specified.
As the amount of c-kit mRNA in the original cells was too low to be detected by the above mentioned exposure condition, RNA from original K562 cells was analyzed using a Fuji Imaging analyzer (BAS2000; Fuji Photo Film CO, Minaiasigara. Kanagawa. Japan) after 48 hours of exposure at room temperature. The blots were finally stained with methylene blue to determine the amounts of RNA on the membranes. In all experiments, control RNA was extracted each time from cells cultured without any treatment. The films and stained membranes were scanned with an Epson GT8000 scanner (Epson, Suwa Nagano, Japan), and the relative density of each lane to that of the control was calculated using image 4 software (public domain software by Wayne Rasband, National Institutes of Health Research Service Branch, Bethesda, MD).
Nuclear run-on transcriptional assay. Cells (2 X 10') were lysed in NP-40 lysis buffer ( l 0 mmol/L Tris-HCI pH 7. were immobilized on nylon membranes (BIODYNE, Pall Corp) using a dot-blot apparatus (Schleicher and Schuell, Keene. NH). Nuclear RNA (5 X IO" cpm/mL) was hybridized in the hybridization buffer (50% formamide, 2X SSC, I % SDS. S X Denhardt's solution. 5 pg/mL tRNA) at 42°C for 4 days. Filters were rinsed in 2X SSC at 55°C. in 2X SSC containing 10 pglmL RNase A at 37°C. and in 0.5X SSC at 55°C for 30 minutes each time and were exposed to x-ray film at -80°C for 10 days.
Western blotting. K562YO cells were exposed to each drug at 37°C for the indicated periods. Cells (4 X IO") were then washed with cold PBS and immediately lysed in 100 pL of lysis buffer containing 20 mmol/L Tris, pH 8.0. I37 mmol/L NaCI, 10% glycerol, 1% Nonidet P-40, 1 mmol/L phenylmethylsulfonyl fluoride (Sigma), 0. I 5 U/mL aprotinin (Sigma), 10 mmol/L EDTA, I0 pg/mL Leupeptin (Sigma), 1 0 0 mmol/L sodium fluoride, and 2 mmol/L sodium orthovanadate (Sigma). The protein concentration of each lysate was measured using the method of Lowry et al. 25 Equal amounts of proteins (36 pg) in each cell lysate were mixed with SDS sample buffer containing 2-mercaptoethanol, heated at 100°C for 5' minutes, and then resolved by SDS-polyacrylamide gel electrophoresis (PAGE) on a 5% to 20% polyacrylamide gradient gel. Thereafter, proteins were electrophoretically transferred onto a polyvinylidene difluoride membrane (Immobilon; Millipore. Bedford, MA). The membranes were blocked, washed with PBS-T (PBS with 0.1% Tween 20). and incubated for 2 hours at room temperature with the anti-c-kit rabbit polyclonal antibody K963 (IBL, Tokyo, Japan): which recognizes 
was measured by blocking new mRNA synthesis with actinomycin D (ActD). Cells were incubated with I O pg/mL of ActD at 37°C for up to IO hours, and the total RNA was analyzed by Northern blotting (exposure time, 48 hours at -80°C). This concentration of ActD inhibited RNA synthesis by less than 5% of the control (data not shown). Analysis of c-kit mRNA in original K562 cells was performed using an image analyzer as described in Materials and Methods. The density of each hybrid was quantified using NIH Image-4 software. The amount of c-kit mRNA was corrected by comparison with the amount of 28s rRNA and then was expressed as a percentage if the amount of c-kit mRNA at time 0 was 100%. The measured half-life of c-kit transcripts in K562YO cells was greater than I O hours, whereas the halflife in the original cells was 2 hours (Fig l) . The turnover of c-kit mRNA in K562YO cells was, therefore, prolonged greater than five times. Nuclear run-on transcriptional assays showed that dot signals from K562YO and original K562 cells were very scant; however, nuclei from K562YO cells treated with dbc-AMP showed an enhancing signal (Fig 5) . These data suggest that the transcription rates of the c-kit gene in both cell lines were equally very low; thus, the prolonged half-life may be a main reason for the high level of c-kit mRNA in K562YO cells.
Effects of cycloheximide on level of c-kit mRNA in K562YO cells. Cycloheximide (CHX), a protein synthesis inhibitor, increased the amount of c-kit mRNA in K562YO cells. K562YO cells were incubated with various concentrations of CHX (0.5 to IO pg/mL) for 4 hours at 37°C or with 5 p g h L of CHX for 24 hours. Total RNA was analyzed by Northern blotting. Concentration of CHX up to 5 pg/mL increased c-kit mRNA in a dose-dependent manner (Fig 2,  lanes I through 5) . Exposure to 5 pg/mL of CHX for 4 hours increased the RNA level to 310% (Fig 2, lane 4) , and this effect also depended on the treatment periods until 24 hours, at which time the level of c-kit mRNA increased to 400% of the control (Fig 2, lane 9) . CHX increased the amount of c-kit mRNA in original K562 cells as well (data not shown). From these results, we postulated two possibilities: either that c-kit mRNA was translated before decaying or that both K562YO and original K562 cells had a CHX-sensitive shortlived factor(s) that facilitated the decay of c-kit mRNA. The prolonged half-life of the c-kit mRNA in K562YO cells is not due to loss of a decay factor(s), if K562YO cells have such a factor(s).
Efsects of serinehhreonine protein kinase modulators on the level of c-kit mRNA in K562YO cells. The level of ckit mRNA in K562YO cells after exposure to protein kinase modulators was analyzed. K562YO cells were incubated with either dbc-AMP (1 mmol/L) and TPA (1 pmol/L) for up to 48 hours at 37"C, or with Calphostin C ( 1 pmol/L) with or without light at 37°C for 30 minutes. Total RNA was analyzed by Northem blotting as described in Materials and Methods. The level of c-kit mRNA was increased by 1 mmol/L of dbc-AMP in a time-dependent manner. After 24 hours, 610% of the control mRNA level was seen (Fig 3A, Forskolin, an activator of adenylate cyclase, also increased mRNA levels (data not shown). One micromolar of TPA gradually decreased the ckit mRNA, which became almost undetectable 6 hours later (Fig 3B, lanes 1 through 4) . However, the mRNA level returned to its previous level 24 hours later (Fig 3B, lane  6) . One micromolar of Calphostin C, which inhibits PKC in the presence of rapidly decreased the mRNA level to 18% of the control within 30 minutes in a light-dependent manner ( Fig 3C, lane 2) . These results indicate that the elevation of intracellular cAMP positively regulated the mRNA level and the inhibition of PKC activity negatively regulated the mRNA level, as PKC activity was downregulated after activation by TPA.".?* Effects qf CHX and ActD on the modulation of c-kit mRNA by TPA and dhc-AMP. We studied whether or not new protein synthesis was needed for regulation of c-kit mRNA levels by TPA and dbc-AMP. K562YO cells were first incubated with 10 &mL of CHX for 1 hour and then further treated with I mmol/L dbc-AMP for an additional 3 hours. As shown in Fig 4A (lane 4) , cAMP added after the incubation with CHX ( I O yglmL) increased the c-kit mRNA level nuclei, and then run-on transcriptional assays of c-kit gene were performed as described in Materials and Methods. K562YO and K562 Ori (original), untreated cell nuclei; dbc-AMP and TPA, treated K562YO cell nuclei.
in K562YO cells to 468% of control. CHX or dbc-AMP alone increased it to 227% and 394% of control, respectively (Fig 4A, lanes 2 and 3) . Elevation of RNA levels by CHX was almost completely blocked after 3 hours' incubation with 1 ymol/L TPA and 2 hours' pre-addition of CHX, although CHX alone elevated the mRNA level to 232% of the control (Fig 4B) . These results suggest that new protein synthesis was not needed for the actions of dbc-AMP and TPA on the level of c-kit mRNA. Next, the effects of ActD inhibition of mRNA synthesis on modulation of the c-kit mRNA level were studied. In this study, cells were first incubated with IO yglmL of ActD for 0.5 hours to inhibit mRNA synthesis and were further incubated with 1 mmoll L dbc-AMP or 1 ymol/L TPA for 3 hours. This preincubation inhibited the upregulation of mRNA by dbc-AMP, although dbc-AMP alone increased it to 329% of control (Fig 4C,  lane 4) . The preincubation with ActD also inhibited the reduction of the mRNA by TPA. TPA alone decreased the RNA level to 22% of the control, but the RNA level with ActD pretreatment was 78% (Fig 4D, lane 4 than in untreated cells, as the dbc-AMP-treated cell nuclei showed an enhancing signal (Fig 5) .
Effects of protein kinase modulators on c-kit protein on the cell suflace. The c-kit protein on the cell surface was analyzed by means of a flow cytometer after the exposure of K562YO cells to protein kinase modulators for the appropriate time periods at 37°C. Until 24 hours, 1 mmol/L of dbc-AMP increased the level of c-kit protein on the cell surface time-dependently (Fig 6, left) . Forskolin also increased c-kit protein on the cell surface (data not shown). On the other hand, 1 pmol/L TPA rapidly decreased the amount of the protein on the cell surface (Fig 6, middle) . The decrease was clearly seen at 10 minutes after the addition. The protein completely disappeared from the cell surface after 6 hours and then returned to the control level after 24 hours (data not shown). Incubation with 1 pmol/L calphostin C for 2 hours in the presence of light increased the c-kit protein on the cell surface, whereas it had no effect in the dark (Fig 6, right) .
Effects of protein kinase modulators on the amount of ckit protein in the whole cell lysate. The amount of c-kit protein in the whole cell lysate was analyzed using the Western blots method. K562YO cells were incubated under the same conditions already described above except for an incubation period. The amount of the protein increased timedependently to 250% of the control 24 hours after the incubation with 1 mmol/L dbc-AMP (Fig 7A, lane 3) . It decreased to 30% of the control in a light-dependent manner after 2 hours in the presence of calphostin C (Fig 7A, lane 4) . Incubation with TPA for 6 hours also decreased it to 38% of the control, but a decrease was not seen in the short incubation periods (up to 2 hours; Fig 7B) . These results suggest that the elevation of the intracellular cAMP level caused upregulation of the protein both on the membrane and in the cytoplasm. The activation and inhibition of PKC caused the rapid downregulation and upregulation, respectively, of c-kit protein on the membrane. The suppression of PKC activities decreased the total amount of protein in the cells.
DISCUSSION
The present results indicate that the high expression of ckit mRNA in K562YO cells was mainly due to the prolonged half-life of this RNA. There are several possible explanations for these results. One possibility is that there are some changes in a factor(s) that controlled the turnover of c-kit mRNA at a posttranscriptional phase. The posttranscriptional prolongation of c-kit mRNA half-life by tumor necrosis factor (U (TNF-(U) and transforming growth factor 0 (TGF-0) in acute myelogenous leukemia (AML) cells has been reported.2*,3n From the results of the CHX treatment, we postulated that K562YO cells could have a CHX-sensitive decay factor(s) for c-kit mRNA. Therefore, some change in a CHXinsensitive stabilizing factor(s) might contribute to the prolonged half-life, rather than the loss of a decay factor(s). Another possibility is that a change in c-kit mRNA itself makes it resistant to decay. We are now investigating the sequence of the c-kit cDNA of K562YO cells.
We also showed that signals initiated by cAMP and PKC could modulate expression of the c-kit gene at various levels from transcription to protein turnover; that is, dbc-AMP enhanced the production of c-kit mRNA in K562YO cells and also increased the c-kit protein on the membrane and in whole cells. Two findings have been reported previously: transcription factor AP-2 mediated transcriptional activation in response to a signal transduction pathway involving CAMP-dependent protein kinase A: ' and there is an AP-2 binding site in the promoter region of the human c-kit protooncogene.'* Therefore, cAMP may be able to enhance the transcription rate of the gene itself through this signal transduction pathway and thereby elevate the mRNA level. Nishina et aI3? previously reported that dbc-AMP increased the level of c-kit mRNA in F9 cells after preincubation with retinoic acid (RA) whereas RA or dbc-AMP alone did not, and the investigators suggested that multisteps were necessary to open the c-kit gene. Our results also showed that dbc-AMP enhanced the expression of the c-kit gene in K562YO cells without any pretreatment, suggesting that the conditioning of the gene to cAMP responsiveness had already occurred in these cells. On the other hand, mechanisms of the action of TPA are strange. New protein synthesis was not necessary for its action, as shown in Fig 4B. However, new RNA synthesis seemed to be necessary for TPA to decrease the c-kit mRNA level, as suggested by the inhibitory action of ActD. Taken together, these findings suggest For personal use only. on June 14, 2017. by guest www.bloodjournal.org From that TPA, at least, seems to work through the new transcription of a gene(s) other than the c-kit gene, but that newly synthesized RNAs do not need to be translated into a protein(s). The precise mechanism remains to be elucidated. Yee et a134 reported that the downregulation of c-kit protein on the cell surface induced by TPA was due to the direct modulation of the membrane protein through the activation of PKC. The same mechanism has also been reported in TPA-induced downregulation in CSF-1 and TNF-a receptor.35*36 Our results suggest that the decrease of the cytoplasmic protein due to c-kit mRNA reduction by TPA also contributed to the late decrease of c-kit membrane protein by TPA.
The SCF/c-kit system is believed to play important roles in hematopoietic stem cell growth and differentiation, and ckit gene transcription is downregulated during hematopoietic cell maturation. We showed that this gene could be regulated at both transcriptional and posttranscriptional levels through serinekhreonine kinases such as PKC and PKA, and that the gene could be expressed at a high level through the modification of posttranscriptional adjustment.
